Upgrade to SI Premium - Free Trial

TD Cowen: 'United Therapeutics Corp. (UTHR) Remains a Top Idea'

May 21, 2026 9:09 AM
TD Cowen analyst Joseph Thome reiterated a Buy rating and $675.00 price target on United Therapeutics Corp. (NASDAQ: UTHR).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments